3860 — EPS Creative Health Technology Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapSucker Stock

Annual income statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	520	453	645	545	458
Cost of Revenue
Gross Profit	76.8	67.8	99.3	94.6	75
Selling / General / Administrative Expenses
Research And Development
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	538	495	662	503	459
Operating Profit	-18.1	-42.4	-17	41.7	-1.07
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-22.7	-48.2	-24.1	33.4	-7.52
Provision for Income Taxes
Net Income After Taxes	-26.3	-50.3	-26.5	30.4	-11
Minority Interest
Net Income Before Extraordinary Items
Net Income	-22.6	-45.7	-22.1	38.6	-13.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-22.6	-45.7	-22.1	38.6	-13.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.045	-0.093	-0.044	0.03	-0.029
Dividends per Share